Uniphar (LON:UPR) Sets New 1-Year Low – Should You Sell?

Uniphar plc (LON:UPR)’s share price hit a new 52-week low during mid-day trading on Friday . The stock traded as low as GBX 166 ($2.09) and last traded at GBX 166 ($2.09), with a volume of 6471 shares changing hands. The stock had previously closed at GBX 169 ($2.12).

Wall Street Analysts Forecast Growth

Separately, Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and set a GBX 310 ($3.90) price target on shares of Uniphar in a research note on Wednesday, September 4th.

Uniphar Trading Down 1.8 %

The business has a 50-day moving average of GBX 185.83 and a 200-day moving average of GBX 205.87. The stock has a market capitalization of £453.21 million, a price-to-earnings ratio of 1,185.71 and a beta of 0.75. The company has a debt-to-equity ratio of 119.43, a quick ratio of 0.60 and a current ratio of 0.90.

Uniphar Company Profile

Headquartered in Dublin, Ireland Uniphar plc is a diversified healthcare services business servicing the requirements of more than 200 multinational pharmaceutical and medical technology
manufacturers across three divisions – Commercial & Clinical, Product Access and Supply Chain & Retail. With a workforce of more than 2,000, the Group is active in Ireland, the UK and the Benelux.